Hospira Mitoxantrone (concentrate) 30 mg/15 mL injection vial USP

Страна: Австралия

Язык: английский

Источник: Department of Health (Therapeutic Goods Administration)

Активный ингредиент:

mitoxantrone (mitozantrone) hydrochloride, Quantity: 2.33 mg/mL

Доступна с:

Hospira Australia Pty Ltd

ИНН (Международная Имя):

mitoxantrone (mitozantrone) hydrochloride

Фармацевтическая форма:

Injection

состав:

Excipient Ingredients: water for injections; sodium acetate trihydrate; glacial acetic acid; sodium chloride; sodium metabisulfite

Администрация маршрут:

Intravenous Infusion

Штук в упаковке:

1 x 15 mL vial

класс:

Medicine Listed (Export Only)

Тип рецепта:

Not scheduled. Not considered by committee

Терапевтические показания :

Mitoxantrone in combination with corticosteroids is indicated as initial chemotherapy for the treatment of patients with pain related to advanced hormone-refractory prostate cancer. Mitoxantrone in combination with other approved drug(s) is indicated in the initial therapy of acute nonlymphocytic leukemia (ANLL) in adults. This category includes myelogenous, promyelocytic, monocytic, and erythroid acute leukemias.

Обзор продуктов:

Visual Identification: A clear, dark blue solution; Container Type: Vial; Container Life Time: 1 Years; Container Temperature: Store between 15-25 degrees Celsius

Статус Авторизация:

Licence status A

Дата Авторизация:

2007-07-27